While treatments for HIV mean that the disease is no longer largely fatal, the world still lacks a true therapy that can eradicate the virus across a globally—and genetically different—population. CD4+ T cells, or helper T cells, in HIV controllers can interact with various HLA class II molecules presenting the same “piece” of HIV. These...
Tag: <span>HIV</span>
Post
Health Officials Agree Undetectable HIV Levels Likely Mean Uninfectious
Medical organizations endorse the “Undetectable = Untransmissible” campaign, which aims to raise awareness of scientific evidence showing that virally suppressed people living with HIV cannot infect others. More than 500 organizations from 67 countries have now endorsed a campaign promoting awareness that virally suppressed HIV-positive people cannot sexually transmit HIV. Launched in early 2016 to...
Post
Pot may alter brain function of some with HIV
(HealthDay)—Using marijuana when you have HIV could lead to problems with brain function if you also abuse alcohol or drugs, a new study finds. “People with HIV infection have many reasons to have cognitive dysfunction, from the virus itself to medications for HIV infection and related conditions, particularly as they age,” said lead researcher Richard...
Post
Scientists May Have Discovered a “Functional Cure” for HIV
IN BRIEF Scientists from The Scripps Research Institute have conducted research into a new way to treat HIV. Their method involves using a compound to subdue the virus’ production and re-activation, which has been successfully tested in mice. SUPPRESSING HIV Science has proposed multiple ways to rid the body of HIV, such as through careful surgery or gene...
Post
USC researcher identifies a new potential way to treat HIV
Targeting human proteins may be a more effective treatment than using “HIV cocktails” to maintain health Medical treatment that boosts the immune system rather than attacking ever-mutating viruses may one day help HIV-positive people whose bodies have built a resistance to anti-HIV cocktails, according to a Keck School of Medicine of USC researcher. I-Chueh Huang has...
Post
Could an experimental injection offer hope for HIV patients? Patient who has the killer virus keeps it at bay for 10 months after treatment
The US military findings offer yet more hope for potential treatments in future Results were presented at the annual meeting of the International Aids Society However, none of the other patients saw such profound effects, experts said The unnamed patient was treated with ‘broadly neutralising antibodies A HIV patient had the killer virus kept under control for...
Post
Injection taken every 2 months to control HIV is the ‘next revolution’ in treating the killer virus – scrapping the need for daily drugs
Currently HIV patients have to take antiretroviral drugs each day to prevent Aids But a Phase II trial proved 2 such drugs in an injection offers as much protection The jabs taken every two months slowly release the medication into the blood A team of international scientists found them to work just as well as...
Post
HIV and the common cold in the firing line of potential new treatment for viral disease
Scientists have long struggled with finding effective ways to fight back against viral infections. An international investigation led by a team from RMIT in Melbourne has uncovered a previously undiscovered biological process that suppresses the body’s natural antiviral response. This research could lead to entirely new treatment strategies for some of the world’s most widespread...
Post
Plant compound more powerful than AZT against HIV
A plant found throughout Southeast Asia traditionally used to treat arthritis and rheumatism contains a potent anti-HIV compound more powerful than the drug AZT, according to a new paper published in the Journal of Natural Compounds. The chemical, patentiflorin A, is derived from the willow-leaved Justicia, and was identified in a screening of more than 4,500 plant...
Post
HIV: A therapeutic advance for resource-limited settings
ANRS 12286 MOBIDIP(1), a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations. Such treatment de-escalation will reduce costs, side effects, and the need...